135 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34167436 | miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. | 2022 Feb | 2 |
2 | 34656559 | Cisplatin resistance of NSCLC cells involves upregulation of visfatin through activation of its transcription and stabilization of mRNA. | 2022 Jan 5 | 2 |
3 | 35139763 | Cancer-associated fibroblast exosomes promote chemoresistance to cisplatin in hepatocellular carcinoma through circZFR targeting signal transducers and activators of transcription (STAT3)/ nuclear factor -kappa B (NF-κB) pathway. | 2022 Mar | 1 |
4 | 35472743 | Thalidomide-based Pt(IV) prodrugs designed to exert synergistic effect of immunomodulation and chemotherapy. | 2022 Jul | 1 |
5 | 35599281 | Synergistic antitumor effect of Andrographolide and cisplatin through ROS-mediated ER stress and STAT3 inhibition in colon cancer. | 2022 May 23 | 3 |
6 | 35628594 | Nimodipine Treatment Protects Auditory Hair Cells from Cisplatin-Induced Cell Death Accompanied by Upregulation of LMO4. | 2022 May 21 | 2 |
7 | 32526010 | IL-23R in laryngeal cancer: a cancer immunoediting process that facilitates tumor cell proliferation and results in cisplatin resistance. | 2021 Feb 11 | 1 |
8 | 33345849 | IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells. | 2021 Mar 5 | 1 |
9 | 33536189 | Lipidome-based Targeting of STAT3-driven Breast Cancer Cells Using Poly-l-glutamic Acid-coated Layer-by-Layer Nanoparticles. | 2021 Apr | 1 |
10 | 33634982 | Arsenic trioxide induces differentiation of cancer stem cells in hepatocellular carcinoma through inhibition of LIF/JAK1/STAT3 and NF-kB signaling pathways synergistically. | 2021 Feb | 2 |
11 | 33878452 | Atezolizumab and blockade of LncRNA PVT1 attenuate cisplatin resistant ovarian cancer cells progression synergistically via JAK2/STAT3/PD-L1 pathway. | 2021 Jun | 1 |
12 | 33982773 | PHF20 inhibition promotes apoptosis and cisplatin chemosensitivity via the OCT4‑p‑STAT3‑MCL1 signaling pathway in hypopharyngeal squamous cell carcinoma. | 2021 Jul | 2 |
13 | 34094941 | lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma. | 2021 | 2 |
14 | 34139285 | Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. | 2021 Oct 10 | 1 |
15 | 34216662 | A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells. | 2021 Aug 31 | 1 |
16 | 34239773 | Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients. | 2021 | 1 |
17 | 34321456 | miR-526b-3p inhibits lung cancer cisplatin-resistance and metastasis by inhibiting STAT3-promoted PD-L1. | 2021 Jul 28 | 1 |
18 | 34329824 | Improved tumor-suppressive effect of OZ-001 combined with cisplatin mediated by mTOR/p70S6K and STAT3 inactivation in A549 human lung cancer cells. | 2021 Oct | 3 |
19 | 34375503 | ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells. | 2021 Sep | 4 |
20 | 34496932 | ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. | 2021 Sep 8 | 2 |
21 | 34543857 | STAT3 contributes to cisplatin resistance, modulating EMT markers, and the mTOR signaling in lung adenocarcinoma. | 2021 Sep 17 | 5 |
22 | 34549307 | SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO/STAT3 axis. | 2021 Nov | 1 |
23 | 34612768 | Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway. | 2021 Dec | 1 |
24 | 31790894 | Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3. | 2020 Jan | 1 |
25 | 31936675 | Curcumin-Mediated Apoptotic Cell Death in Papillary Thyroid Cancer and Cancer Stem-Like Cells through Targeting of the JAK/STAT3 Signaling Pathway. | 2020 Jan 9 | 3 |
26 | 31974389 | The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity. | 2020 Jan 23 | 1 |
27 | 32010312 | Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway. | 2020 Feb | 1 |
28 | 32080166 | ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy. | 2020 Feb 20 | 1 |
29 | 32170433 | CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. | 2020 Jul | 1 |
30 | 32252293 | Expression of CD44v6-Containing Isoforms Influences Cisplatin Response in Gastric Cancer Cells. | 2020 Apr 2 | 1 |
31 | 32351887 | Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells. | 2020 | 2 |
32 | 32661236 | Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer. | 2020 Jul 13 | 1 |
33 | 32705214 | A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells. | 2020 Sep | 3 |
34 | 32757663 | HOTAIR Promotes Cisplatin Resistance of Osteosarcoma Cells by Regulating Cell Proliferation, Invasion, and Apoptosis via miR-106a-5p/STAT3 Axis. | 2020 Jan-Dec | 1 |
35 | 32767949 | A Ferrocene Derivative Reduces Cisplatin Resistance in Breast Cancer Cells through Suppression of MDR-1 Expression and Modulation of JAK2/STAT3 Signaling Pathway. | 2020 | 3 |
36 | 32828740 | Central nervous system (CNS) tumor cell heterogeneity contributes to differential platinum-based response in an in vitro 2D and 3D cell culture approach. | 2020 Oct | 1 |
37 | 32901049 | Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling. | 2020 Sep 8 | 2 |
38 | 33023532 | TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells. | 2020 Oct 6 | 1 |
39 | 33044324 | Long noncoding RNA nuclear-enriched abundant transcript 1 regulates proliferation and apoptosis of neuroblastoma cells treated by cisplatin by targeting miR-326 through Janus kinase/signal transducer and activator of transcription 3 pathway. | 2020 Dec 9 | 2 |
40 | 33116826 | ARHGAP6 Promotes Apoptosis and Inhibits Glycolysis in Lung Adenocarcinoma Through STAT3 Signaling Pathway. | 2020 | 6 |
41 | 30332965 | Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells. | 2019 | 1 |
42 | 30352127 | Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21. | 2019 Jun | 1 |
43 | 30483799 | Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells. | 2019 Feb | 1 |
44 | 30747218 | Gallic acid has anticancer activity and enhances the anticancer effects of cisplatin in non‑small cell lung cancer A549 cells via the JAK/STAT3 signaling pathway. | 2019 Mar | 2 |
45 | 30777616 | Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro. | 2019 May | 1 |
46 | 30808674 | Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer. | 2019 May 15 | 1 |
47 | 30811078 | The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin. | 2019 Nov | 4 |
48 | 30961670 | Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway. | 2019 Apr 8 | 3 |
49 | 31037726 | Modulation of Myb-induced NF-kB -STAT3 signaling and resulting cisplatin resistance in ovarian cancer by dietary factors. | 2019 Nov | 1 |
50 | 31105696 | Atezolizumab and Bevacizumab Attenuate Cisplatin Resistant Ovarian Cancer Cells Progression Synergistically via Suppressing Epithelial-Mesenchymal Transition. | 2019 | 1 |